Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
29.54
-1.30 (-4.20%)
Feb 21, 2025, 4:00 PM EST - Market closed
Tectonic Therapeutic Employees
Tectonic Therapeutic had 44 employees as of December 31, 2023.
Employees
44
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,215,409
Market Cap
435.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 44 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
TECX News
- 17 days ago - Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data - Seeking Alpha
- 19 days ago - Tectonic Announces $185 Million Private Placement - GlobeNewsWire
- 23 days ago - Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF - GlobeNewsWire
- 6 weeks ago - Tectonic Therapeutic: Protein Engineering Platform For GPCRs - Seeking Alpha
- 2 months ago - Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024 - GlobeNewsWire
- 3 months ago - Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference - GlobeNewsWire
- 3 months ago - Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein - GlobeNewsWire
- 4 months ago - Tectonic Therapeutic to Present Phase 1a Data at AHA 2024 - GlobeNewsWire